FR EN

Back


28/09/2011
Signing of an Acquisition of a Controlling Interest in Novagali Pharma S.A. by Santen Pharmaceutical Co. Ltd.
Santen Pharmaceutical, a leading Japanese pharmaceutical company, and Novagali Pharma S.A. a French biopharmaceutical company specializing in ophthalmology and focusing on new ocular therapeutics, announce today that Santen, Novagali and certain of its shareholders, including IdInvest Partners have entered into a share purchase agreement whereby Santen shall acquire shares...
Read more on Reuters.com




X

X

X